📊 Score Breakdown
Offering Ability
65
Cash Runway
65
Float Risk
75
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split
65%
• 50-day avg $0.84 below $1 exchange minimum
• 7 months cash with weak price
🔁 Convertible Conversion
60%
• Major convertible overhang: 34% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
53%
• Under 12 months cash (7mo)
• Active shelf registration ($10M, 31% of market cap)
💹 Market Data
Market Cap$32.02M
Shares Outstanding47.73M
Float18.34M
Cash$2.10M
Debt$6.27M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 492.6K shares
#1
Geode Capital Management, LLC
123.6K shares
#2
Vanguard Group Inc
103.2K shares
#3
Blackrock Inc.
91.2K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest2.28M
Days to Cover1.0
% of Float12.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
424B3
ATM
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
🔬 More Research for ARAI
📊 ARAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ARAI Signal Convergence & Dark Pool Activity — StonkWhisper
📄 ARAI Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.